Berlin – SMP advised medical cannabis producer and wholesaler DEMECAN on its new financing round. New investors as well as several existing shareholders participated in the investment in the upper single-digit million range. DEMECAN already relied on the expertise of the law firm in previous financing rounds and was again comprehensively legally advised by a Team led by SMP partner Martin Schaper. The financing will be used for further growth and the expansion of the production facility near Dresden into Europe's most modern facility for the cultivation and further processing of medicinal cannabis.
"DEMECAN operates as the only independent German production and trading company for medical cannabis in a growing market. We are pleased to be part of the developments," said Martin Schaper.
Further information can be found in German on the company website.
SMP is a boutique law firm for tax and business law which is active in the core fields of Tax, Funds, Corporate, Litigation and Transactions. The attorneys and tax specialists at SMP represent a broad client base, which ranges from emerging technology companies and family-run SMEs to large corporations as well as private equity and venture capital funds. Founded in 2017, SMP has become one of the leading players for venture capital, private equity and fund structuring in Germany. The firm and its partners have been recognized nationally and internationally by JUVE, Best Lawyers, Legal 500, Focus and Chambers and Partners. Today, SMP has more than 60 experienced lawyers and tax specialists in three Offices in Berlin, Hamburg and Cologne.